Papaya

Dosage for Papaya as an allergenic extract is not standardized by weight or volume in the same way as traditional medications. Instead, it is based on the concentration of the extract and the method of administration.

• Skin Prick Testing (SPT): A single drop of a 1:20 w/v (weight to volume) or 1:10 w/v extract is applied to the skin (usually the forearm or back). A sterile lancet is then used to prick the skin through the drop. The result is read 15 to 20 minutes later.
• Intradermal Testing: If the skin prick test is negative but a high clinical suspicion of allergy remains, a healthcare provider may inject 0.02 mL of a much more dilute solution (e.g., 1:1000 or 1:100) into the dermis. This carries a higher risk of systemic reaction.
• Oral Enzyme Supplements: Common doses for papain-based supplements range from 50 mg to 500 mg per meal, though these are not FDA-standardized for medical treatment.

Papaya allergenic extracts can be used in children, but the procedure must be performed with extreme caution.

• Infants and Children: The dosage (the amount applied during a skin test) is the same as adults, but the number of tests performed at one time is often limited to reduce the risk of systemic reactions.
• Safety: Testing is generally avoided in children with severe, uncontrolled asthma, as they are at higher risk for severe reactions to the test itself.

Renal Impairment

No specific dosage adjustments are required for renal impairment due to the minimal systemic absorption of the diagnostic extract. However, patients with end-stage renal disease may have altered skin reactivity (uremic pruritus), which can make skin test results difficult to interpret.

Hepatic Impairment

No dosage adjustments are necessary for patients with liver disease. The metabolic load of a diagnostic skin test is negligible.

Elderly Patients

In patients over 65, skin reactivity may be diminished. Healthcare providers may need to use a stronger positive control (histamine) to ensure the skin is capable of mounting a response before interpreting a negative papaya test.

For Diagnostic Testing

1. 1Preparation: You must stop taking antihistamines (e.g., diphenhydramine, cetirizine, loratadine) for at least 3 to 7 days before the test, as these will block the allergic response and lead to a false-negative result.
2. 2Administration: The test is performed in a clinic. The skin is cleaned with alcohol, the extract is applied, and the skin is pricked.
3. 3Observation: You must remain in the clinic for at least 30 minutes after the test to be monitored for signs of a systemic allergic reaction (anaphylaxis).

For Oral Supplements

• Timing: Take with or immediately after meals to aid in protein digestion.
• Swallowing: Tablets should be chewed or swallowed as directed on the label. Do not exceed the recommended daily intake.

For diagnostic testing, a missed appointment simply means the test must be rescheduled. For oral supplements, if you miss a dose with a meal, take it as soon as you remember during or shortly after the meal. If it is almost time for your next meal, skip the missed dose. Do not double the dose.

Signs of Overdose (Systemic Reaction)

• Generalized hives or itching
• Swelling of the lips, tongue, or throat
• Difficulty breathing or wheezing
• Rapid drop in blood pressure (fainting or dizziness)
• Nausea, vomiting, or abdominal cramping

Emergency Measures

In the event of an overdose or systemic reaction during testing, the healthcare provider will immediately administer epinephrine (EpiPen) and may provide oxygen, intravenous fluids, and antihistamines. If an overdose of oral supplements occurs, contact a Poison Control Center, though the primary risk is gastrointestinal upset.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt self-testing without medical guidance.

When Papaya is used as an allergenic extract for skin testing, localized reactions are the most common and, in fact, the intended effect for a positive diagnosis.

• Localized Wheal and Flare: A raised, itchy bump (wheal) surrounded by redness (flare) at the site of the test. This typically appears within 15 minutes and subsides within 1 to 2 hours.
• Pruritus (Itching): Intense itching at the test site is very common and can be managed with a topical corticosteroid or oral antihistamine after the test has been read.
• Local Irritation: Mild soreness or tenderness where the skin was pricked.

• Delayed Local Reaction: Some patients may experience swelling and redness at the test site 6 to 24 hours after the procedure. This is usually not dangerous but can be uncomfortable.
• Gastrointestinal Distress: When taking oral papaya enzymes, some individuals report mild stomach cramps, bloating, or diarrhea, especially if taken on an empty stomach.
• Oral Irritation: Chewing papaya enzyme tablets can sometimes cause a burning sensation in the mouth or throat due to the proteolytic (protein-dissolving) nature of papain.

• Systemic Urticaria: Hives appearing on parts of the body away from the test site.
• Lymphangitis: Very rarely, inflammation of the lymph vessels extending from the test site may occur.
• Esophageal Perforation: Extremely rare reports exist of papain enzymes causing irritation or damage to the esophagus if a tablet becomes lodged, particularly in patients with pre-existing esophageal narrowing.

> Warning: Stop taking Papaya products and call your doctor immediately or seek emergency care if you experience any of the following:

• Anaphylaxis: This is a life-threatening allergic reaction. Symptoms include a sudden feeling of warmth, a rash that spreads rapidly, swelling of the throat, a 'lump in the throat' sensation, rapid pulse, and a sharp drop in blood pressure.
• Angioedema: Severe swelling under the skin, particularly around the eyes, lips, or genitals.
• Bronchospasm: Sudden wheezing, chest tightness, or shortness of breath that occurs shortly after exposure to the extract or enzyme.
• Severe Hypotension: Feeling faint, dizzy, or losing consciousness, which may indicate the onset of anaphylactic shock.

There are no known long-term side effects associated with the occasional use of Papaya allergenic extracts for diagnostic purposes. However, chronic use of high-dose oral papain supplements may theoretically lead to:

• Sensitization: Repeated exposure to papaya enzymes in supplement or powder form can actually cause someone to develop an allergy to papaya over time.
• Gastrointestinal Erosion: Prolonged use of high-strength proteolytic enzymes might irritate the lining of the stomach in susceptible individuals.

There are currently no FDA black box warnings for non-standardized papaya allergenic extracts. However, the FDA has issued strong warnings in the past regarding unapproved topical papain products, which were associated with reports of permanent vision loss when used near the eyes and severe hypersensitivity reactions. All allergenic extracts carry an inherent risk of anaphylaxis, which is why they must only be administered by trained professionals.

Report any unusual symptoms or persistent reactions to your healthcare provider immediately.

Papaya allergenic extract is intended solely for diagnostic use by clinicians experienced in the management of allergic diseases. It is not for therapeutic injection. Because of the risk of severe systemic reactions, including anaphylaxis, the extract should only be used in settings equipped with emergency resuscitative equipment, including epinephrine, oxygen, and airway management tools. Patients should be informed that a positive skin test does not always correlate with a clinical allergy; the results must be interpreted in the context of the patient's medical history.

No FDA black box warnings for Papaya allergenic extracts. However, clinicians are cautioned that non-standardized extracts have variable potency, and extreme care must be taken when switching between different manufacturers or lots of the extract.

• Allergic Reactions / Anaphylaxis Risk: The most significant risk is a systemic allergic reaction. This is more likely in patients with high levels of specific IgE or those who have had previous severe reactions to papaya or cross-reactive substances like latex, kiwi, or avocado.
• Latex-Fruit Syndrome: Patients with a known allergy to natural rubber latex should be treated as high-risk for papaya allergy. Approximately 30-50% of individuals with latex allergy show hypersensitivity to certain plant-derived foods, including papaya.
• Asthma Status: Patients with unstable or severe asthma are at a significantly higher risk for a fatal outcome if a systemic reaction occurs during skin testing. Testing should be deferred until the patient's asthma is well-controlled.
• Skin Conditions: Testing should not be performed on skin areas affected by active dermatitis, eczema, or psoriasis, as this can lead to false-positive results or exacerbate the skin condition.

• Immediate Observation: Patients must be monitored for a minimum of 30 minutes following the administration of a skin test.
• Vital Signs: In high-risk patients, baseline blood pressure and heart rate should be recorded before testing.
• Follow-up: Patients should be instructed to report any 'late-phase' reactions (swelling or hives occurring hours after leaving the clinic).

Papaya extracts do not typically affect the ability to drive. However, if a patient experiences a systemic reaction or is given antihistamines or epinephrine to treat a reaction, they should not drive until they are fully recovered and cleared by a physician.

There are no direct pharmacological interactions between papaya extract and alcohol. However, alcohol consumption can increase peripheral vasodilation, which might theoretically increase the rate of allergen absorption or worsen the severity of an allergic reaction.

For diagnostic extracts, there is no 'discontinuation' process. For oral supplements, they can generally be stopped without a tapering period. However, if a patient has developed a sensitivity to the enzyme, they should avoid all papaya-derived products indefinitely.

> Important: Discuss all your medical conditions, especially respiratory issues and previous allergic reactions, with your healthcare provider before starting Papaya testing or supplements.

There are few absolute contraindications for drug combinations, but the following must be avoided to ensure safety and accuracy:

• Beta-Blockers (e.g., Propranolol, Atenolol): Patients taking beta-blockers may be resistant to the effects of epinephrine. If a patient on a beta-blocker has an anaphylactic reaction to a papaya skin test, the standard treatment (epinephrine) may be ineffective, leading to a potentially fatal outcome. Many allergists consider beta-blocker use a relative or absolute contraindication for skin testing.

• ACE Inhibitors (e.g., Lisinopril, Enalapril): These medications can interfere with the body's ability to degrade kinins, potentially making an allergic reaction more severe or prolonged.
• Tricyclic Antidepressants (e.g., Amitriptyline): These drugs have potent antihistamine properties and can suppress the skin's response to the allergen, leading to a false-negative result for up to 2 weeks after discontinuation.

• Antihistamines (H1 and H2 Blockers): Medications like loratadine (Claritin), cetirizine (Zyrtec), and famotidine (Pepcid) will significantly inhibit the wheal and flare reaction. These must be stopped several days before testing.
• Topical Corticosteroids: If applied to the test site, these can suppress the local inflammatory response. They should be avoided on the testing area for at least 2-3 weeks.
• Systemic Corticosteroids: Long-term use of high-dose oral steroids (e.g., Prednisone) may dampen skin reactivity, though short courses are less likely to interfere significantly.

• Cross-Reactive Foods: If a patient is undergoing testing for papaya, they may also react to kiwi, banana, avocado, chestnut, and fig. Consuming these foods immediately before a test might theoretically prime the immune system for a stronger reaction.
• Alcohol: As noted, alcohol can increase blood flow to the skin and may enhance the inflammatory response during a skin test.

• St. John's Wort: While not a direct interaction, some herbal supplements can affect skin sensitivity or general immune tone. It is best to disclose all herbal use to the allergist.
• Proteolytic Enzymes: Taking other enzyme supplements (like bromelain from pineapple) may increase the risk of gastrointestinal side effects if taken with oral papaya enzymes.

• Skin Prick Tests: Papaya extract is itself used to generate a 'lab result' on the skin. Its accuracy is entirely dependent on the absence of interfering drugs like antihistamines.
• IgE Blood Tests (ImmunoCAP): Taking papaya enzymes orally does not usually interfere with blood tests for papaya-specific IgE, but the clinical history is always the most important factor.

For each major interaction, the management strategy involves either discontinuing the interfering medication for an appropriate washout period or choosing an alternative diagnostic method (like a blood test) that is not affected by the medication.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any heart or blood pressure medications.

Papaya allergenic extract must NEVER be used in the following circumstances:

• Previous Severe Anaphylaxis to Papaya: If a patient has a history of a life-threatening reaction to papaya, skin testing may be too dangerous. In such cases, an in vitro (blood) test for IgE is preferred.
• Uncontrolled Asthma: Patients with a Forced Expiratory Volume in 1 second (FEV1) of less than 70% of predicted, or those with frequent exacerbations, are at extreme risk of death from a systemic reaction during testing.
• Dermatographism: This is a condition where the skin becomes raised and red with even minor stroking. In these patients, the skin test will always appear 'positive' regardless of whether an allergy exists, making the test useless.

Conditions requiring a careful risk-benefit analysis include:

• Pregnancy: While not directly harmful to the fetus, an anaphylactic reaction in the mother could cause fetal hypoxia (lack of oxygen). Testing is usually deferred until after delivery.
• Beta-Blocker Therapy: Due to the risk of epinephrine resistance during anaphylaxis.
• Acute Infection: The immune system may be hyper-reactive during an infection, potentially leading to less predictable test results.

Patients should be aware of cross-sensitivity between papaya and:

• Natural Rubber Latex: Due to shared proteins like class I chitinases.
• Other Fruits: Specifically those in the 'latex-fruit' group (kiwi, avocado, banana).
• Papain-containing Products: Such as certain meat tenderizers, contact lens cleaners, and some beers (where papain is used as a clarifying agent).

> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to latex or tropical fruits, before prescribing Papaya testing.

Pregnancy Category: Not Classified. There are no adequate and well-controlled studies of papaya allergenic extract in pregnant women. Most allergists recommend avoiding skin testing during pregnancy because of the risk of systemic anaphylaxis, which can lead to uterine contractions, placental hypoperfusion, and fetal distress. If a diagnosis is essential, blood testing (IgE ImmunoCAP) is the safer alternative as it poses no risk of a systemic reaction to the mother or fetus.

It is not known whether components of papaya allergenic extract are excreted in human milk. However, because the amount used in skin testing is so small and systemic absorption is minimal, it is generally considered unlikely to affect a nursing infant. Nevertheless, the decision to test should be made after discussing the risks and benefits with a healthcare provider.

Skin testing with papaya extract is common in the pediatric population to investigate food allergies.

• Age Limits: There is no absolute lower age limit, but infants under 6 months may have less reactive skin, leading to smaller wheals.
• Safety: The risk of systemic reactions is present in children, and the number of tests performed at one time should be minimized.
• Growth Effects: There are no known effects on growth or development from diagnostic papaya extracts.

• Skin Reactivity: Patients over the age of 65 often show reduced skin wheal responses to both allergens and histamine controls. This can lead to false-negative results.
• Comorbidities: Elderly patients are more likely to have cardiovascular disease or be taking medications like beta-blockers or ACE inhibitors, which increases the risk and complexity of managing a systemic reaction.
• Polypharmacy: Careful review of the patient's medication list is essential to identify drugs that interfere with testing.

In patients with chronic kidney disease, the skin may be less responsive or, conversely, may be prone to 'itchiness' (uremia) that interferes with the reading of the test. No specific dose adjustments are needed, but results must be interpreted cautiously.

There is no evidence that liver disease affects the response to or safety of papaya allergenic extracts. Standard diagnostic protocols should be followed.

> Important: Special populations require individualized medical assessment. Always inform your specialist if you are pregnant, breastfeeding, or have underlying heart or kidney conditions.

Papaya allergenic extract contains various proteins, the most significant being papain (Carica papaya allergen 1). In the context of an allergy, these proteins act as antigens. When introduced into the skin of a sensitized individual, these antigens cross-link specific IgE antibodies bound to the surface of mast cells and basophils. This cross-linking triggers a signal transduction cascade involving tyrosine kinases, leading to the release of pre-formed mediators like histamine and the de novo synthesis of leukotrienes and cytokines. These substances cause the classic allergic 'wheal and flare' response.

• Onset: The localized allergic response typically begins within 5 minutes of administration.
• Peak Effect: The wheal and flare reaction usually reaches its maximum size between 15 and 20 minutes.
• Duration: The visible reaction generally fades within 1 to 2 hours, although a late-phase reaction can occur 6 to 12 hours later in some individuals.
• Dose-Response: While higher concentrations of extract generally produce larger wheals, the relationship is non-linear and varies significantly between individuals based on their level of sensitization.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (Epicutaneous) |

| Protein Binding | N/A (Local Action) |

| Half-life | N/A (Proteins degraded locally) |

| Tmax | 15-20 minutes (for local reaction) |

| Metabolism | Local proteolytic degradation |

| Excretion | Renal (trace amounts of metabolites) |

• Composition: A complex mixture of water-soluble proteins, glycoproteins, and polysaccharides extracted from Carica papaya.
• Key Allergen: Papain (MW ~23,000 Da), a cysteine protease consisting of a single polypeptide chain with three disulfide bridges.
• Solubility: Highly soluble in aqueous solutions and glycerin-based buffers.

Papaya belongs to the class of Non-Standardized Food Allergenic Extracts. Unlike 'standardized' extracts (like those for grass pollen or dust mites), papaya extracts do not have a federally mandated potency unit (like BAU or AU). Their potency is determined by the weight/volume ratio of the extraction process.